MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), is a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical...

Long-term follow-up results from the pivotal Phase 3 RESONATE™ trial (PCYC-1112) showed continued survival rates in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small...

Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced a new family of wideband plastic...

Bruker is show-casing several new and innovative, high-performance mass spectrometry solutions for metabolomics, proteoform profiling and toxicology at ASMS 2017 (www.asms.org). Bruker is also...

IMBRUVICA (ibrutinib) reduced cells that may play an important role in the survival and proliferation of chronic lymphocytic leukemia (CLL), without negatively impacting non-cancerous immune...

MiNDERA has been selected as a finalist for Red Herring's Top 100 North America award, one of the technology industry's most prestigious prizes. Finalists for the awards are among the continent's...

XTI Aircraft Company (XTI) announced today it has been selected by the Paris Air Lab Programming Committee to exhibit at the Paris Air Show. The exhibit space is hosted by the French Aerospace...

IBM (NYSE: IBM), its Research Alliance partners GLOBALFOUNDRIES and Samsung, and equipment suppliers have developed an industry-first process to build silicon nanosheet transistors that will...

The Diamond Producers Association (DPA) announced today at the JCK show that their 2017 full-year marketing investment of $57 million has been released by the Board of Directors. Building on the...

Encouraging results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (NASDAQ: HALO) were presented today at the American...